✦ LIBER ✦
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer
✍ Scribed by Ramazan Yildiz; Mustafa Benekli; Suleyman Buyukberber; Ali Osman Kaya; Banu Ozturk; Emel Yaman; Veli Berk; Ugur Coskun; Deniz Yamac; Banu Sancak; Aytug Uner
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 272 KB
- Volume
- 136
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.